Wei Yang
59Patents
8h-index
52Co-inventors
81Inventor score
Filing activity: Jun 15, 2000 → Dec 30, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7176279B2 | Cyclic peptide compositions and methods for treatment of sexual dysfunction | Emerging Cross-Sectional Technologies | 23 | Expired |
| US7795221B2 | Linear natriuretic peptide constructs | Human Necessities | 14 | Active |
| US8114844B2 | Linear and cyclic melanocortin receptor-specific peptidomimetics | Chemistry; Metallurgy | 13 | Active |
| US7473760B2 | Cyclic peptide compositions for treatment of sexual dysfunction | Emerging Cross-Sectional Technologies | 13 | Expired |
| US7417027B2 | Linear and cyclic melanocortin receptor-specific peptides | Human Necessities | 12 | Expired |
| US7396814B2 | Metallopeptide compositions for treatment of sexual dysfunction | Human Necessities | 11 | Expired |
| US7049398B1 | Melanocortin metallopeptide constructs, combinatorial libraries and applications | Human Necessities | 11 | Expired |
| US9556475B2 | Amplification reporter with base-pairing oligomers | Chemistry; Metallurgy | 9 | Active |
| US8492517B2 | Melanocortin-1 receptor-specific cyclic peptides | Human Necessities | 7 | Active |
| US8487073B2 | Melanocortin receptor-specific peptides for treatment of sexual dysfunction | Human Necessities | 7 | Active |
| US8877890B2 | Melanocortin-1 receptor-specific cyclic peptides | Human Necessities | 7 | Active |
| US7307063B2 | Melanocortin metallopeptides for treatment of sexual dysfunction | Human Necessities | 6 | Expired |
| US8455617B2 | Melanocortin receptor-specific peptides | Human Necessities | 5 | Active |
| US8933194B2 | Melanocortin-1 receptor-specific linear peptides | Emerging Cross-Sectional Technologies | 5 | Active |
| US11085070B2 | Amplification reporter with base-pairing oligomers | Chemistry; Metallurgy | 5 | Active |
| US10604789B2 | Amplification reporter with base-pairing oligomers | Chemistry; Metallurgy | 5 | Active |
| US7897721B2 | Cyclic peptide compositions for treatment of sexual dysfunction | Emerging Cross-Sectional Technologies | 5 | Active |
| US8846601B2 | Melanocortin receptor-specific peptides | Emerging Cross-Sectional Technologies | 4 | Active |
| US7745188B2 | Thermostable Y-family polymerases and chimeras | Chemistry; Metallurgy | 4 | Active |
| US7795378B2 | Peptide compositions for treatment of sexual dysfunction | Human Necessities | 4 | Active |
| US7622440B2 | Cyclic natriuretic peptide constructs | Human Necessities | 3 | Active |
| US8729224B2 | Melanocortin receptor-specific peptides for treatment of female sexual dysfunction | Human Necessities | 3 | Active |
| US9447148B2 | Melanocortin-1 receptor-specific cyclic peptides | Human Necessities | 3 | Active |
| US11597078B2 | Machine learning control of object handovers | Physics | 3 | Active |
| US9040663B2 | Melanocortin receptor-specific peptides | Human Necessities | 3 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.